In this workshop Ron will discuss the benefits of discrete-event simulation for Health Economic investigations that are conducive for decision-making by payers and providers, and talk through a "Real-World" application example.
Today more than ever governments and health providers are under extreme pressure to reduce costs while maintaining patient quality of life. Accuracy of information presented to them is critical for acceptance. This workshop will justify the use of discrete-event simulation by health economists as a means to provide accurate assessments of value for medical products or services.
Health Economic Modeling The International Society for Pharmacoeconomicsand Outcomes Research (ISPOR) Task Force on GoodResearch Practices – Modeling Studies:"[...] an analytic methodology that accounts for events overtime and across populations, that is based on data drawnfrom primary and/or secondary sources, and whosepurpose is to estimate the effects of an intervention onvalued health consequences and costs.“1
Health Economic Modeling The aim of health economic modeling is to generate expected values for theclinical and economic effects of therapeutic alternatives
Health Economic ModelingAdvantages of Discrete-Event SimulationReal-World SIMUL8 ModelReferencesQuestions
References1. Weinstein MC, et.al. Principles of good practice for decision analytic modeling in health-careevaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. ValueHealth. 2003, Jan-Feb;6(1):9-17.2. Sun X, Faunce T. Decision-analytical modelling in health-care economic evaluations. Eur J HealthEcon, 2008, 9:313-323.3. Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens K, Cohen D, Kunz KM. State- Transition Modeling:A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Value in Health, 2012,(15):812-820.4. Pidd M. Computer Simulation in Management Science (5th ed). New York: John Wiley & Sons, 2004.5. Jacobson SH, Hall SN, Swisher JR. Discrete-event simulation of health care systems, patient ﬂow:reducing delay in healthcare delivery. Int Ser Oper Res Manag Sci 2006;91:211–52.6. Figge MT. Stochastic discrete event simulation of germinal center reactions. Phys Rev E Stat NonlinSoft Matter Phys 2005;71:1–9.7. Zand MS, Briggs BJ, Bose A, Vo T. Discrete event modeling of CD4 memory T cell generation. JImmunol 2004;173:3763–72.8. Coelli FC, Ferreira RB, Almeida RM, Pereira WC. Computer simulation and discrete-event models inthe analysis of a mammography clinic patient ﬂow. Computer Methods Programs Biomed2007;87:201–7.
References9. Comas M, Castells X, Hoffmeister L, et al. Discrete-event simulation applied to the analysis ofwaiting lists: evaluation of a prioritization system for cataract surgery. Value Health 2008;11:1203–13.10. Stahl JE, Rattner D, Wiklund R, et al. Reorganizing the system of care surrounding laparoscopicsurgery: a cost-effectiveness analysis using discrete-event simulation. Med Decis Making2004;24:461–71.11. Clark DE, Hahn DR, Hall RW, Quaker RE. Optimal location for a helicopter in a rural trauma system:prediction using discrete-event computer simulation. Proc Annu Symp Comput Appl Med Care1994;888 –92.12. Chase D, Roderick P, Cooper K, et al. Using simulation to estimate the cost effectiveness ofimproving ambulance and thrombolysis response times after myocardial infarction. Emerg Med J2006;23:67–72.13. Skolnik JM, Barrett JS, Jayaraman B, et al. Shortening the timeline of pediatric phase I trials: therolling six design. J Clin Oncol 2008;26:190–5.14. Barth-Jones DC, Adams AL, Koopman JS. Monte Carlo simulation experiments for analysis of HIVvaccine effects and vaccine trial design. Winter Simul Conf Proc 2000;2:1985–94.15. Groothuis S, van Merode GG. Discrete event simulation in the health policy and managementprogram. Methods Inf Med 2000;39:339–42.
References16. Mar J, Arrospide A, Comas M. Budget impact analysis of thrombolysis for stroke in Spain: adiscrete event simulation model. Value Health 2010;13:69 –76.17. Stahl JE, Vacanti JP, Gazelle S. Assessing emerging technologies—the case of organ replacementtechnologies: volume, durability, cost. Int J Technol Assess Health Care 2007;23:331– 6.18. Caro JJ, Moller J, Getsios D. Discrete Event Simulation: The Preferred Technique for HealthEconomic Evaluations? Value in Health. 2010, Vol 13(8):1056-1060.19. Barton P, Bryan S, Robinson S (2004) Modelling in the economic evaluation of health care:selecting the appropriate approach. J Health Serv Res Policy 9: 110–118.20. Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation ofhealth technologies. Health Econ. 15: 1295–1310 (2006).21. Cairo JJ. Pharmacoeconomic Analyses Using Discrete Event Simulation. Pharmacoeconomics2005; 23 (4): 323-332.22. Weinstein MC. Recent developments in decision-analytic modelling for economic evaluation.Pharmacoeconomics. 2006; 24(11):1043–53.23. Karnon J. Alternative decision modelling techniques for the evaluation of health caretechnologies: Markov processes versus discrete event simulation. Health Econ.2003;12(10):837–48.
References24. Kamon J, Brown J. Selecting a decision model for economic evaluation: a case study andreview. Health Care Management Science 1 (1998) 133–140.25. Simpson KN, Strassburger A, Jones WJ, Dietz B, Rajagopalan R. Comparison of Markov Modeland Discrete-Event Simulation Techniques for HIV. Pharmacoeconomics 2009; 27 (2): 159-165.